1.
Giustolisi R, Fantozzi N, Staltari M, Marchiori J, Mastrangelo O, Marcucci R, Mirra F, Mazzotta P, Gabrieli CB, The Luce Study Group. Combined intravitreal ranibizumab and verteporfin photodynamic therapy versus ranibizumab alone for the treatment of age-related macular degeneration. Digit J Ophthalmol [Internet]. 2011 Sep. 30 [cited 2024 May 5];17(3):23-30. Available from: https://djo.harvard.edu/index.php/djo/article/view/597